(Q40900688)

24 September 2017

title

Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study (English)

1 reference

24 September 2017

0 references

3

1 reference

24 September 2017

4

1 reference

24 September 2017

Elke Leuridan

6

0 references

Pierre Van Damme

series ordinal

5

object named as

Pierre Van Damme

1 reference

24 September 2017

Kirsten Maertens

1

1 reference

24 September 2017

Raïssa Nadège Caboré

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

16 November 2015

1 reference

24 September 2017

1 reference

24 September 2017

volume

34

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

142-150

1 reference

The seroepidemiology of Bordetella pertussis infection in Western Europe

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Recent developments in pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

How best to estimate the global burden of pertussis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Natural history of pertussis antibody in the infant and effect on vaccine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Pertussis: an important target for maternal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Changing pertussis epidemiology: everything old is new again

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Kinetics of maternal antibodies against rubella and varicella in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Immune responses in infants whose mothers received Tdap vaccine during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Combined tetanus-diphtheria and pertussis vaccine during pregnancy: transfer of maternal pertussis antibodies to the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Laboratory Diagnosis of Pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Correlates of protection induced by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Safety of pertussis vaccination in pregnant women in UK: observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

The case for maternal vaccination against pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

The protective role of maternally derived antibodies against Bordetella pertussis in young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Effect of maternal antibodies on the infant immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Role of maternal pertussis antibodies in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

The relationship between concentration of specific antibody at birth and subsequent response to primary immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.100

10.1016/J.VACCINE.2015.10.100

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference